What Do The 1:1 THCV:THC Smokiez x VIVA Edibles Feel Like?
If you’ve tried the 1:1:1 (THCV:THC:CBD) gummies already, you’ll know a little of what you’re in for: an even-keel, clear-headed and energized high that won’t leave you with the munchies or anxiety. But these new 1:1 gummies are a little different, and we’re here to explain why.
But first, for the newcomers, a little introduction:
VIVA specializes in THCV: a rare cannabinoid with amazing effects on the human body. Along with its energizing properties, it’s been studied for its possible uses in aiding those with anxiety and diabetes.* VIVA has spent close to a decade breeding our plants to get the highest percentages and purest forms (live resin) of THCV possible, and we’re stoked to partner with Smokiez to bring THCV edibles to the state of Oregon.
With the new one to one ratio (THCV:THC), THCV really shines. The result is a euphoric, energized high that allows you to focus in on whatever task is at hand, be it video games, assembling IKEA furniture, or PRing at the gym.
Working together (per the entourage theory), THCV brings its own boost to your typical THC sativa experience, leaving users clear-headed and alert while still blissfully high.
With the CBD in the 1:1:1’s, the overall effect is a total-body euphoric and uplifting sensation with the same boost of energy and alertness, but with a little less of an edge. The CBD helps even more with not triggering anxiety, and the THCV works to curb any munchies you might feel otherwise.
This new gummy boosts both mood and energy, giving users an uplifting sensation and (be careful), the feeling that you could do anything you put your mind to.
But don’t take our word for it. Go on, give ‘em a try.
Disclaimer: These statements are simply opinions of the writer for VIVA, NOT medical advice or instruction.
Source:
*Abioye, A., Akinwekomi, A., Ayodele, O., Marinkovic, A., Patidar, R., & Sanyaolu, A. (2020, January 31). Δ9-Tetrahydrocannabivarin (THCV): a commentary on potential therapeutic benefit for the management of obesity and diabetes. Journal of Cannabis Research. https://jcannabisresearch.biomedcentral.com/articles/10.1186/s42238-020-0016-7